Markets

BAT Shares Gain on Continued Buyback Activity, Investors Eye Regulatory Decisions

British American Tobacco shares advanced in early London trading following the company's disclosure of further buyback activity, as investors monitor upcoming regulatory decisions and the ex-dividend date.

Daniel Marsh · · · 2 min read · 8 views
BAT Shares Gain on Continued Buyback Activity, Investors Eye Regulatory Decisions
Mentioned in this article
BTI $60.99 +3.60% PM $183.65 -2.06%

Shares of British American Tobacco PLC moved higher during Tuesday's morning session in London after the company revealed additional repurchases under its ongoing stock buyback initiative. The tobacco giant's stock traded at 4,340 pence by 0829 GMT, representing a gain of 0.8% from the previous close.

The company reported purchasing 112,212 of its own shares on February 16, continuing a program that has become a key component of its capital return strategy. Share buybacks reduce the number of outstanding shares, which can boost earnings per share and return capital to investors.

This financial maneuver takes place against a backdrop of strategic transformation for the London-based company. British American Tobacco has been allocating substantial resources toward expanding its portfolio of reduced-risk products, including nicotine pouches and vaping devices, while simultaneously employing shareholder returns to maintain investor support during this transitional period.

In a separate regulatory filing on Monday, the company disclosed that Chief Executive Tadeu Marroco, along with a closely associated individual, each acquired 157 shares through the reinvestment of dividend proceeds. While a relatively small transaction, such insider activity is often monitored by market participants for signals about executive confidence.

The stock last settled at 4,305 pence when markets closed on Monday. Last week, the company released full-year financial results showing annual profit growth, driven in part by market share gains for its Velo nicotine pouch brand in the United States. Management also highlighted an artificial intelligence-driven productivity initiative that may lead to workforce reductions, though interim Chief Financial Officer Javed Iqbal indicated it was premature to specify potential job impact numbers.

Regulatory developments continue to influence the investment thesis. British American Tobacco has indicated that a potential U.S. import prohibition on unauthorized disposable vaping products could reduce the illicit market by approximately one-third. A final determination from the U.S. International Trade Commission is anticipated in March 2026, followed by a 60-day presidential review period.

Competitive dynamics remain intense within the nicotine pouch category. Philip Morris International's Zyn brand currently leads the U.S. market, though analysts including Jefferies' Andrei Andon-Ionita have suggested British American Tobacco is well-positioned to capture additional segment share.

Established risks persist, including volume erosion to illicit products, accelerated regulatory tightening, and margin pressure from pricing competition. The company's recent results statement noted the vapor category "continues to be impacted by illicit proliferation" and cited fiscal and regulatory headwinds in markets such as Bangladesh and Australia.

Market attention now turns to two imminent events: the March ITC decision regarding U.S. vape imports and the company's dividend schedule. Shares are scheduled to trade ex-dividend on March 26, with the subsequent payment slated for May 7 according to London Stock Exchange timetables.

This article is for informational purposes only and does not constitute financial advice or a recommendation to buy or sell any security. Market data may be delayed. Always conduct your own research and consult a licensed financial advisor before making investment decisions.

Related Articles

View All →